...
首页> 外文期刊>Journal of endourology >Photoselective laser vaporization of the prostate in the treatment of bladder outlet obstruction in advanced-stage prostate cancer: A single-center experience
【24h】

Photoselective laser vaporization of the prostate in the treatment of bladder outlet obstruction in advanced-stage prostate cancer: A single-center experience

机译:前列腺的光选择性激光汽化治疗晚期前列腺癌的膀胱出口梗阻:单中心经验

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Purpose: The study in China is the first on photoselective vaporization of the prostate (PVP) applied to bladder outlet obstruction (BOO) or urinary retention from advanced-stage prostate cancer (PCa). The aim is to evaluate the efficacy and safety of PVP in the treatment of patients with BOO secondary to advanced-stage PCa. Patients and Methods: Forty-five patients (mean age 76.13±5.88 years, range 62-89 years) with BOO or urinary retention secondary to advanced-stage PCa received PVP with a potassium-titanyl-phosphate laser. The treatment outcome was evaluated with subjective and objective tests at 1, 3, 6, and 12 months after PVP using the International Prostate Symptom Score (IPSS), quality of life (QoL) score, postvoid residual (PVR) urine volume, and maximum urinary flow rate (Qmax). The operative time, indwelling catheterization time, and operative complications were also observed. Results: All 45 patients recovered without incident. The mean operative time was 50±7.6 minutes. The catheterization duration was 3.2 days (range 2-7 days). There was significant improvement in Qmax from 7.29±0.93 to 12.16±2.75mL/sec after treatment at 12 months. Mean PVR volume decreased from 210.94±179.49 to 54.45±33.16mL. Mean IPSS score decreased from preoperative 28.19±3.64 to postoperative 14.61±2.81 (P<0.05), QoL score decreased from 5.03±0.69 to 3.66±0.65 (P<0.05). There were no intraoperative adverse events. Postoperative complications included mild transient hematuria in 12 (26.7%) patients and mild dysuria in 11 (24.4%) patients within 4 weeks. Conclusions: The clinical results suggest that PVP is a safe, efficient, and less-invasive treatment for patients with BOO or urinary retention secondary to advanced-stage PCa.
机译:背景与目的:中国的这项研究是首次将前列腺的光选择性汽化(PVP)用于膀胱出口梗阻(BOO)或晚期前列腺癌(PCa)的尿retention留。目的是评估PVP在晚期PCa继发的BOO患者中的疗效和安全性。患者和方法:45例BOO或晚期PCa继发尿retention留的患者(平均年龄76.13±5.88岁,范围62-89岁)接受了磷酸钛氧钛钾激光治疗的PVP。使用国际前列腺症状评分(IPSS),生活质量(QoL)评分,排尿后残留(PVR)尿量和最大尿量,在PVP后1、3、6和12个月通过主观和客观测试评估治疗结果尿流率(Qmax)。还观察了手术时间,留置导尿时间和手术并发症。结果:全部45例患者均康复,无意外。平均手术时间为50±7.6分钟。导尿持续时间为3.2天(范围2-7天)。治疗12个月后,Qmax从7.29±0.93升至12.16±2.75mL / sec,显着提高。平均PVR体积从210.94±179.49毫升降低至54.45±33.16毫升。平均IPSS评分从术前的28.19±3.64降低到术后的14.61±2.81(P <0.05),QoL评分从5.03±0.69降低到3.66±0.65(P <0.05)。没有术中不良事件。术后并发症包括4周内12例(26.7%)的轻度短暂性血尿和11例(24.4%)的轻度排尿困难。结论:临床结果表明,对于晚期PCa继发的BOO或尿retention留的患者,PVP是一种安全,有效且微创的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号